XML 16 R4.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Per Share data
3 Months Ended 6 Months Ended 248 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Condensed Consolidated Statements of Operations [Abstract]          
Revenue   $ 93 $ 50 $ 93 $ 3,131
Operating expenses:          
Research and development 30,296 26,160 56,585 56,651 1,322,677
General and administrative 8,890 11,196 20,652 21,306 360,253
In-process research and development costs         19,726
Goodwill impairment         151,428
Total operating expenses 39,186 37,356 77,237 77,957 1,854,084
Loss from operations (39,186) (37,263) (77,187) (77,864) (1,850,953)
Other income (expense) 47 (1,257) 1,397 (2,047) (1,220)
Interest expense on note payable to related party (2,509) (2,523) (4,985) (4,625) (22,436)
Interest expense on senior convertible notes (2,834) (1,211) (5,247) (2,421) (23,100)
Interest income 2 3 17 6 36,988
Loss before provision for income taxes (44,480) (42,251) (86,005) (86,951) (1,860,721)
Income taxes         (26)
Net loss (44,480) (42,251) (86,005) (86,951) (1,860,747)
Deemed dividend related to beneficial conversion feature of convertible preferred stock         (22,260)
Accretion on redeemable preferred stock         (952)
Net loss applicable to common stockholders $ (44,480) $ (42,251) $ (86,005) $ (86,951) $ (1,883,959)
Net loss per share applicable to common stockholders - basic and diluted $ (0.37) $ (0.37) $ (0.71) $ (0.77)  
Shares used to compute basic and diluted net loss per share applicable to common stockholders 121,708 113,116 121,385 113,105 0